Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Oxygenta Pharmaceutical Ltd has made a disclosure under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, filed via BSE. Regulation 30 disclosures cover material corporate events such as board changes, mergers, acquisitions, new projects, or financial results. The specific content of the disclosure is not available in the provided headline. Investors should refer to the full filing on BSE to understand the exact nature of the announcement.
Without details of the disclosure, it is not possible to assess the impact on the stock or shareholders. Investors are advised to check the full filing on the BSE website for clarity on whether it relates to a positive (new order, expansion), neutral (compliance update), or negative (regulatory action, management change) event.